NantHealth founder Patrick Soon-Shiong and two additional pharma executives are being sued by attorneys Boyden Grey and Adam Walden of Washington, D.C., for allegedly attempting to acquire the startup Altor Bioscience through a sweetheart deal.
The lawsuit, filed Wednesday, asserts that the deal in place benefits Soon-Shiong, Hing C. Wong and Fred Middleton -- all board members of Altor Bioscience. The deal comes at the expense of the minority shareholders, which breaches their fiduciary duty.
